Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

ClinicalTrials.gov ID: NCT01896232

Public ClinicalTrials.gov record NCT01896232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Multiple-dose, Two-arm, Active-controlled, Double-blind, Double-dummy Study to Compare the Therapeutic Efficacy and Safety of Oral Doses of Cinacalcet HCl With Intravenous Doses of AMG 416 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to demonstrate that treatment with etelcalcetide (AMG 416) is not inferior to treatment with cinacalcet for lowering serum parathyroid hormone (PTH) levels by \> 30% from baseline among patients with chronic kidney disease (CKD) and secondary hyperparathyroidism (SHPT) who require management with hemodialysis.

Study identification

NCT ID
NCT01896232
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
683 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 13, 2013 (Actual)
Primary completion
Nov 12, 2014 (Actual)
Completion
Jan 8, 2015 (Actual)
Last update posted
Jul 18, 2019

2013 – 2015

United States locations

U.S. sites
41
U.S. states
16
U.S. cities
40
Facility City State ZIP Site status
Research Site Azusa California 91702 —
Research Site Bakersfield California 93306 —
Research Site Bakersfield California 93309 —
Research Site Chula Vista California 91910 —
Research Site Covina California 91723 —
Research Site Granada Hills California 91344 —
Research Site La Mesa California 91942 —
Research Site La Puente California 91744 —
Research Site Los Angeles California 90022 —
Research Site San Diego California 92123 —
Research Site San Gabriel California 91776 —
Research Site Whittier California 90603 —
Research Site Arvada Colorado 80002 —
Research Site Aurora Colorado 80045 —
Research Site Longmont Colorado 80501 —
Research Site Westminster Colorado 80031 —
Research Site Orange Connecticut 06477 —
Research Site Pembroke Pines Florida 33028 —
Research Site Pinecrest Florida 33156 —
Research Site Tampa Florida 33614 —
Research Site Baton Rouge Louisiana 70808 —
Research Site Lafayette Louisiana 70501 —
Research Site Southgate Michigan 48195 —
Research Site Columbus Mississippi 39705 —
Research Site Gulfport Mississippi 39501 —
Research Site Sewell New Jersey 08080 —
Research Site Great Neck New York 11021 —
Research Site Mineola New York 11501 —
Research Site Ridgewood New York 11385 —
Research Site Rosedale New York 11422 —
Research Site The Bronx New York 10461 —
Research Site Wilmington North Carolina 28401 —
Research Site Cincinnati Ohio 45206 —
Research Site Columbus Ohio 43215 —
Research Site Philadelphia Pennsylvania 19106 —
Research Site Houston Texas 77030 —
Research Site San Antonio Texas 78229 —
Research Site Burlington Vermont 05401 —
Research Site Fairfax Virginia 22033 —
Research Site Portsmouth Virginia 23704 —
Research Site Madison Wisconsin 53713 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 141 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01896232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01896232 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →